Publikacje w NEJM, JAMA i Lancet z udziałem IK 2005-2012

1. Alexander JH, Lopes RD, James S, Kilaru R, He Y, Mohan P, Bhatt DL, Goodman S, Verheugt FW, Flather M, Huber K, Liaw D, Husted SE, Lopez-Sendon J, De Caterina R, Jansky P, Darius H, Vinereanu D, Cornel JH, Cools F, Atar D, Leiva-Pons JL, Keltai M, Ogawa H, Pais P, Parkhomenko A, Ruzyllo W, Diaz R, White H, Ruda M, Geraldes M, Lawrence J, Harrington RA, Wallentin L, the APPRAISE-2 Investigators.: Apixaban with Antiplatelet Therapy after Acute Coronary Syndrome. N Engl J Med. 2011; 365(8): 699-708 (IF=53.486; MNiSW=40).
   
   
2. Antman EM, Morrow DA, McCabe CH, Murphy SA, Ruda M, Sadowski Z, Budaj A, Lopez-Sendon JL, Guneri S, Jiang F, White HD, Fox KA, Braunwald E, ExTRACT-TIMI 25 Investigators.: Enoxaparin versus unfractionated heparin with fibrinolysis for ST-elevation myocardial infarction. N Engl J Med. 2006; 354(14): 1477-1488. (IF=51.296; MNiSW=30).
   
   
3. Jones RH, Velazquez EJ, Michler RE, Sopko G, Oh JK, O'Connor CM, Hill JA, Menicanti L, Sadowski Z, Desvigne-Nickens P, Rouleau JL, Lee KL, the STICH Hypothesis 2 Investigators.: Coronary Bypass Surgery with or without Surgical Ventricular Reconstruction. N Engl J Med. 2009; 360(17):1705-1715. (IF=47.050; MNiSW=40).
   
   
4. Haller H, Ito S, Izzo JL Jr, Januszewicz A, Katayama S, Menne J, Mimran A, Rabelink TJ, Ritz E, Ruilope LM, Rump LC, Viberti G, for the ROADMAP Trial Investigators*.: Olmesartan for the Delay or Prevention of Microalbuminuria in Type 2 Diabetes. N Engl J Med. 2011; 364(10): 907-17. (IF=53.486; MNiSW=40).
   
   
5. Hochman JS, Lamas GA, Buller CE, Dzavik V, Reynolds HR, Abramsky SJ, Forman S, Ruzyllo W, Maggioni AP, White H, Sadowski Z, Carvalho AC, Rankin JM, Renkin JP, Steg PG, Mascette AM, Sopko G, Pfisterer ME, Leor J, Fridrich V, Mark DB, Knatterud GL, Occluded Artery Trial Investigators.: Coronary intervention for persistent occlusion after myocardial infarction. N Engl J Med. 2006; 355(23): 2395-2407. (IF=51.296; MNiSW=30).
   
   
6. Kjekshus J, Apetrei E, Barrios V, Bohm M, Cleland JG, Cornel JH, Dunselman P, Fonseca C, Goudev A, Grande P, Gullestad L, Hjalmarson A, Hradec J, Janosi A, Kamensky G, Komajda M, Korewicki J, Kuusi T, Mach F, Mareev V, McMurray JJ, Ranjith N, Schaufelberger M, Vanhaecke J, van Veldhuisen DJ, Waagstein F, Wedel H, Wikstrand J, the CORONA Group.: Rosuvastatin in Older Patients with Systolic Heart Failure. N Engl J Med. 2007; 357: 2248-2261 (IF=52.589; MNiSW=40).
   
   
7. Mega J, Braunwald E, Mohanavelu S, Burton P, Poulter R, Misselwitz F, Hricak V, Barnathan E, Bordes P, Witkowski A, Markov V, Oppenheimer L, Gibson C, on behalf of the ATLAS ACS-TIMI 46 study group.: Rivaroxaban versus placebo in patients with acute coronary syndromes (ATLAS ACS-TIMI 46): a randomised, double-blind, phase II trial. Lancet. 2009; 374(9683): 29-38. (IF=30.758; MNiSW=40).
   
   
8. Neumann HP, Vortmeyer A, Schmidt D, Werner M, Erlic Z, Cascon A, Bausch B, Januszewicz A, Eng C.: Evidence of MEN-2 in the original description of classic pheochromocytoma. N Engl J Med. 2007; 357(13): 1311-1315. (IF=52.589; MNiSW=40).
   
   
9. Nissen SE, Nicholls SJ, Wolski K, Rodes-Cabau J, Cannon CP, Deanfield JE, Despres JP, Kastelein JJ, Steinhubl SR, Kapadia S, Yasin M, Ruzyllo W, Gaudin C, Job B, Hu B, Bhatt DL, Lincoff AM, Tuzcu EM, STRADIVARIUS Investigators.: Effect of rimonabant on progression of atherosclerosis in patients with abdominal obesity and coronary artery disease: the STRADIVARIUS randomized controlled trial. JAMA. 2008; 299(13): 1547-1560. (IF=31.718; MNiSW=40).
   
   
10. Nissen SE, Tardif JC, Nicholls SJ, Revkin JH, Shear CL, Duggan WT, Ruzyllo W, Bachinsky WB, Lasala GP, Tuzcu EM, ILLUSTRATE Investigators.: Effect of torcetrapib on the progression of coronary atherosclerosis. N Engl J Med. 2007; 356(13): 1304-1316. (IF=52.589; MNiSW=40).
    
    
11. Schiavi F., Boedeker C., Bausch B., Pęczkowska M., Fuentes Gomez C., Strassburg T., Pawlu C., Buchta M., Salzman M., Hoffman M., Berlis A., Brink I., Cybulla M., Muresan M., Walter M., Forrer F., Valimaki M., Kawecki A., Szutkowski A., Schipper J., Walz M., Pigny P., Bauters C., Willet-Brozick J., Baysal B., Januszewicz A., Eng C., Opocher G., Neumann H.: Predictors and Prevalance of Paraganglioma Syndrome Associated With Mutations of the SDHC Gene. JAMA, 2005; 294 (16): 2057 2063.(IF=23.494; MNiI=24).
    
    
12. Teerlink JR, Metra M, Felker GM, Ponikowski P, Voors AA, Weatherley BD, Marmor A, Katz A, Grzybowski J, Unemori E, Teichman SL, Cotter G.: Relaxin for the treatment of patients with acute heart failure (Pre-RELAX-AHF): a multicentre, randomised, placebo-controlled, parallel-group, dose-finding phase IIb study. Lancet. 2009; 373(9673): 1429-1439. (IF=30.758; MNiSW=40).
    
    
13. Tricoci P, Huang Z, Held C, Moliterno DJ, Armstrong PW, Van de Werf F, White HD, Aylward PE, Wallentin L, Chen E, Lokhnygina Y, Pei J, Leonardi S, Rorick TL, Kilian AM, Jennings LH, Ambrosio G, Bode C, Cequier A, Cornel JH, Diaz R, Erkan A, Huber K, Hudson MP, Jiang L, Jukema JW, Lewis BS, Lincoff AM, Montalescot G, Nicolau JC, Ogawa H, Pfisterer M, Prieto JC, Ruzyllo W, Sinnaeve PR, Storey RF, Valgimigli M, Whellan DJ, Widimsky P, Strony J, Harrington RA, Mahaffey KW, the TRACER Investigators.: Thrombin-Receptor Antagonist Vorapaxar in Acute Coronary Syndromes. N Engl J Med. 2012; 366(1): 20-33. (IF=53.486; MNiSW=40)
    
    
14. Velazquez EJ, Lee KL, Deja MA, Jain A, Sopko G, Marchenko A, Ali IS, Pohost G, Gradinac S, Abraham WT, Yii M, Prabhakaran D, Szwed H, Ferrazzi P, Petrie MC, O'Connor CM, Panchavinnin P, She L, Bonow RO, Rankin GR, Jones RH, Rouleau JL, the STICH Investigators.: Coronary-Artery Bypass Surgery in Patients with Left Ventricular Dysfunction. N Engl J Med. 2011; 346(17): 1607-1616, (IF=53.486; MNiSW=40).
    
    
15. Wiviott SD, Braunwald E, McCabe CH, Montalescot G, Ruzyllo W, Gottlieb S, Neumann FJ, Ardissino D, De Servi S, Murphy SA, Riesmeyer J, Weerakkody G, Gibson CM, Antman EM, TRITON-TIMI 38 Investigators.: Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med. 2007; 357(20): 2001-2015. (IF=52.589; MNiSW=40).